← Back to Clinical Trials
Recruiting NCT06060548

Role of Novel ILR in the Management of PVCs

Trial Parameters

Condition PVC - Premature Ventricular Contraction
Sponsor Kansas City Heart Rhythm Research Foundation
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2022-04-20
Completion 2025-09
Interventions
Monitoring of patients presenting with PVCs

Brief Summary

This prospective, observational study is a single center clinical registry of patients referred for management of symptomatic or asymptomatic Premature Ventricular Contractions (PVCs). Subjects will be followed through 12 months. The study will enroll approximately 50 patients.

Eligibility Criteria

Inclusion Criteria: * Patients \> 18 years of age * Have a Medtronic LINQ II ILR * Willing and able to give written informed consent Exclusion Criteria: * History of myocardial infarction * Significant flow-limiting coronary artery disease (≥50% stenosis) on invasive coronary angiography or Computed tomography angiography (CTA). * History of cardiac arrest * With existing implantable defibrillators * Currently pregnant

Related Trials